Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

PURPOSE: To investigate the therapeutic effectiveness and safety of Janus kinase 1 inhibitor upadacitinib in adolescent patients with atopic dermatitis (AD). PATIENTS AND METHODS: This study examined therapeutic effectiveness and safety of upadacitinib for 39 Japanese adolescent patients (aged 12–17...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagino, Teppei, Hamada, Risa, Yoshida, Mai, Fujimoto, Eita, Saeki, Hidehisa, Kanda, Naoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638939/
https://www.ncbi.nlm.nih.gov/pubmed/37953857
http://dx.doi.org/10.2147/CCID.S439053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638939/
https://www.ncbi.nlm.nih.gov/pubmed/37953857
http://dx.doi.org/10.2147/CCID.S439053

Ejemplares similares